SABBY 13G PMCB 8.30.21

Company

PharmaCyte Biotech, Inc.

Filed

August 30, 2021

Accession Number

0001535610-21-000094

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →